Watch Ticker

Theriva Biologics, Inc.

Go to Theriva Biologics, Inc. Website

$0.40

-0.02 (-5.85%)

Live

Previous Close

$0.4239

Day Range

$0.3923 - $0.42

Previous Day Range

$0.4073 - $0.447

Market Cap

$3.9 million USD

Day Vol.

292046

Previous Day Vol.

313006

Currency

USD

Primary Exchange

NYSE American, LLC

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor strom...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Rishabh Mishra - US Stocks To Open Higher On Shortened Trading Day: Santa Claus Rally Period Officially Begins, Says Analyst

US stock futures are trading higher ahead of a shortened trading session on Christmas Eve. Analysts expect a 'Santa Rally' during this period, which has historically seen positive returns. However, they also caution about potential market corrections in 2025 due to stretched valuations.

Related tickers: AVGR, CREV, CREVW, NEUE, TIVC, TOVX, SPY, QQQ.

Read Full Article

Theriva Biologics, Inc. - Theriva™ Biologics anuncia la orientación de la FDA estadounidense con respecto al diseño del estudio de Fase 3 del VCN-01 para el tratamiento del cáncer de páncreas metastásico

Theriva Biologics announced that the FDA provided guidance on the design of a Phase 3 study for their lead candidate VCN-01 in combination with standard chemotherapy for the treatment of metastatic pancreatic cancer. The FDA recommended conducting an independent Phase 3 study of VCN-01 with gemcitabine/nab-paclitaxel, rather than expanding the ongoing Phase 2b VIRAGE study.

Related tickers: TOVX.

Read Full Article

Trending Tickers

Please sign in to view